MTSS1 Overexpression Correlates with Poor Prognosis in Colorectal Cancer

Journal of Gastrointestinal Surgery

Volumn 15, Issue 7, 2011, Pages 1205-1212

  Wang, Ding ^a   Xu, Mei rong ^a   Wang, Tao ^a   Li, Ting ^a   Zhu, Jian wei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Immunohistochemistry; MTSS1; Prognosis; Western blot

Indexed keywords

ACTIN BINDING PROTEIN; MTSS1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROGNOSIS; WESTERN BLOTTING;

BLOTTING, WESTERN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79958778095     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-011-1546-2     Document Type: Article

References (18)

1. Sung JJ, Lau JY, Goh KL, et al. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6(11): 871-6.
2. Lee YG, Macoska JA, Korenchuk S, et al. MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia. 2002; 4(4): 291-4.
3. Lin J, Liu J, Wang Y, et al. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene. 2005; 24(12): 2059-66.
4. Yamagishi A, Masuda M, Ohki T, et al. A novel actin bundling/filopodium-forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein. J Biol Chem. 2004; 279(15): 14929-36.
5. Loberg RD, Neeley CK, Adam-Day LL, et al. Differential expression analysis of M IM (MTSS1) sp lice variants and a functional role of MIM in prostate cancer cell biology. Int J Oncol. 2005; 26(6): 1699-1705.
6. Wang Y, Liu J, Smith E, et al. Downregulation ofmissing in metastasis gene (MIM) is associated with the p rogression of bladder transitional carcinomas. Cancer Invest. 2007; 25(2): 79-86.
7. Wang Y, Zhou K, Zeng X, et al. Tyrosine phosphorylation of missing in metastasis protein is implicated in platelet-derived growth factor-mediated cell shape changes. J Biol Chem. 2007; 282(10): 7624-7631.
8. Lee YY, Yu CP, Lin CK, et al. Expression of survivin and cortactin in colorectal adenocarcinoma: Association with clinicopathological parameters. Dis Markers 2009; 26: 9-18.
9. Nixdorf S, Grimm MO, Loberg R, et al. Expression and regulation of MIM (Missing in Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett. 2004; 215: 209-22.
10. Parr C, Jiang WG. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer. 2009; 45(9): 1673-83.
11. Liu K, Wang GF, Ding HZ, et al. Downregulation of metastasis suppressor 1 (MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer. 2010; 10: 428-37.
12. Callahan CA, Ofstad T, Horng L, et al. MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev. 2004; 18(22): 2724-9.
13. Woodings JA, Sharp SJ, Machesky LM. MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J. 2003; 371: 463-71.
14. Utikal J, Gratchev A, Muller-Molinet I, et al. The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation. Int J Cancer. 2006; 119(10): 2287-2293.
15. Huang XY, Huang ZL, Tang ZY, et al. Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection. Zhonghua Yi Xue Za Zhi. 2010; 90(18): 1278-82.
16. Ma S, Guan XY, Lee TK, et al. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol. 2007; 38(8): 1201-6.
17. Gonzalez-Quevedo R, Shoffer M, Horng L, et al. Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4. J Cell Biol. 2005. 168(3): 453-63.
18. Bershteyn M, Atwood SX, Woo WM, et al. MIM and Cortactin Antagonism Regulates Ciliogenesis and Hedgehog Signaling. Dev Cell. 2010; 19(2): 270-83.